Carasent ASA
OSE:CARA
Intrinsic Value
Carasent ASA is an investment management company, which in the development of entrepreneurial and e-health solutions. [ Read More ]
The intrinsic value of one CARA stock under the Base Case scenario is 15.48 NOK. Compared to the current market price of 18.75 NOK, Carasent ASA is Overvalued by 17%.
Valuation Backtest
Carasent ASA
Run backtest to discover the historical profit from buying and selling CARA stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Carasent ASA
Current Assets | 446.2m |
Cash & Short-Term Investments | 373.9m |
Receivables | 65m |
Other Current Assets | 7.3m |
Non-Current Assets | 660.9m |
PP&E | 50m |
Intangibles | 610.9m |
Other Non-Current Assets | -1k |
Current Liabilities | 115.2m |
Accounts Payable | 19.2m |
Accrued Liabilities | 33.7m |
Other Current Liabilities | 62.3m |
Non-Current Liabilities | 47m |
Long-Term Debt | 37.1m |
Other Non-Current Liabilities | 9.9m |
Earnings Waterfall
Carasent ASA
Revenue
|
250.9m
NOK
|
Cost of Revenue
|
-45.1m
NOK
|
Gross Profit
|
205.9m
NOK
|
Operating Expenses
|
-241.8m
NOK
|
Operating Income
|
-35.9m
NOK
|
Other Expenses
|
-20m
NOK
|
Net Income
|
-56m
NOK
|
Free Cash Flow Analysis
Carasent ASA
CARA Profitability Score
Profitability Due Diligence
Carasent ASA's profitability score is 42/100. The higher the profitability score, the more profitable the company is.
Score
Carasent ASA's profitability score is 42/100. The higher the profitability score, the more profitable the company is.
CARA Solvency Score
Solvency Due Diligence
Carasent ASA's solvency score is 67/100. The higher the solvency score, the more solvent the company is.
Score
Carasent ASA's solvency score is 67/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
CARA Price Targets Summary
Carasent ASA
According to Wall Street analysts, the average 1-year price target for CARA is 26.27 NOK with a low forecast of 25.25 NOK and a high forecast of 27.83 NOK.
Shareholder Return
CARA Price
Carasent ASA
Average Annual Return | 74.21% |
Standard Deviation of Annual Returns | 138.19% |
Max Drawdown | -80% |
Market Capitalization | 1.4B NOK |
Shares Outstanding | 72 324 781 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Carasent ASA is an investment management company, which in the development of entrepreneurial and e-health solutions. The company is headquartered in Oslo, Oslo. The company went IPO on 2002-04-08. The company operates through its subsidiary Evimeria EMR AB, which offers digital eHealth services primarily at specialist care, primary care and paramedics. The firm provides Webdoc, a Web-based care management system for health professionals that reduces the risk of resource-intensive routines. The system is customizable and also offers integration solutions. The firm is active in the Nordic region.
Contact
IPO
Employees
Officers
The intrinsic value of one CARA stock under the Base Case scenario is 15.48 NOK.
Compared to the current market price of 18.75 NOK, Carasent ASA is Overvalued by 17%.